Showing results (421-430 of 745) with videos related to
Sort By:
Pageof 75
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 7, 2019
A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypesJoseph Park, Michael G Levin, Christopher M Haggerty, et al.The New England Journal of Medicine|January 12, 2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemiaMarina Cuchel, LeAnne T Bloedon, Philippe O Szapary, et al.Human Gene Therapy. Clinical Development|September 28, 2013
Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemiaShu-Jen Chen, Julio Sanmiguel, Martin Lock, et al.Circulation|November 21, 2025
OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque DevelopmentRobert D Schwab, David Degaramo, Seok Jae Hong, et al.Obesity (Silver Spring, Md.)|March 19, 2013
Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokinesSubhasish Bose, Parasuram Krishnamoorthy, Ajay Varanasi, et al.Plos Medicine|October 8, 2020
Genetics of height and risk of atrial fibrillation: A Mendelian randomization studyMichael G Levin, Renae Judy, Dipender Gill, et al.Cell Metabolism|July 7, 2021
Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoidsWenxiang Hu, Chunjie Jiang, Mindy Kim, et al.Circulation|February 23, 2017
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention SettingPradeep Natarajan, Robin Young, Nathan O Stitziel, et al.Nature Cardiovascular Research|May 16, 2022
Endothelial plasticity drives aberrant vascularization and impedes cardiac repair after myocardial infarctionMenggui Huang, Fan Yang, Duo Zhang, et al.Journal of Lipid Research|November 12, 2010
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionCatherine E Watson, Nicole Weissbach, Lise Kjems, et al.Pageof 75